Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FJEDR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,738
Award facts
- Contract value 100% obligated
- $15,737.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,737.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. TRELEGY ELLIPTA is a combination respiratory maintenance medication used in chronic obstructive pulmonary disease management, representing the type of specialized pharmaceutical commodity routinely procured through the DLA medical supply chain.
This delivery order is a child action under AmerisourceBergen's larger SPE2DX indefinite delivery contract valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company maintains an extensive federal contract portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All reviewed contract awards from this vendor demonstrate competitive procurement practices with consistent firm fixed-price delivery order structures, reflecting DLA's standardized approach to pharmaceutical procurement through pre-established vehicle contracts.
Quick answers
Who was awarded contract SPE2DB25FJEDR?
SPE2DB25FJEDR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FJEDR worth?
The government has obligated $15,738 on SPE2DB25FJEDR.
Is contract SPE2DB25FJEDR an order under another contract?
Yes. SPE2DB25FJEDR is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB25FJEDR competed?
The extent of competition for SPE2DB25FJEDR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award